Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens

This publication has 41 references indexed in Scilit:

• Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1
  Scientific Reports, 2013
• Ad5:Ad48 Hexon Hypervariable Region Substitutions Lead to Toxicity and Increased Inflammatory Responses Following Intravenous Delivery
  Molecular Therapy, 2012
• Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
  Clinical Infectious Diseases, 2012
• Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
  The Journal of Infectious Diseases, 2012
• Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors
  Molecular Therapy, 2011
• International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
  Vaccine, 2011
• Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
  Clinical Infectious Diseases, 2011
• HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
  The Lancet, 2008
• Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
  Published by Elsevier ,2008
• Vaccines for preventing influenza in healthy children
  Published by Wiley ,2008